Early signs look good for BTG's varicose vein treatment

Healthcare firm BTG has successfully completed the first phase of the US-based trial of Varisolve, a varicose vein treatment.

Healthcare firm BTG has successfully completed the first phase of the US-based trial of Varisolve, a varicose vein treatment.

The study showed that patients treated with the product demonstrated a "statistically significant improvement" in symptoms, compared with patients who received a placebo. They also reported a significant improvement in appearance.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.